Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
M.D. Anderson Cancer Center
Tempus AI
NRG Oncology
M.D. Anderson Cancer Center
Black Diamond Therapeutics, Inc.
Elevation Oncology
Inhibrx Biosciences, Inc
Pfizer
Fusion Pharmaceuticals Inc.
Rutgers, The State University of New Jersey
pharmaand GmbH
Fate Therapeutics
Fred Hutchinson Cancer Center
West Virginia University
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Tetra Bio-Pharma
InSightec
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of Wisconsin, Madison
Yale University
University of Kentucky
CureOne
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Cota Inc.
University of Florida
Virginia Commonwealth University
Masonic Cancer Center, University of Minnesota
New York State Psychiatric Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Virginia Commonwealth University
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Yale University
Pharmacyclics LLC.
Pfizer
Calando Pharmaceuticals
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Auron Healthcare GmbH
Emory University
The University of Texas Health Science Center at San Antonio
University of Wisconsin, Madison